Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006083 |
YEM_ID: | YEM-791 |
ID: | TCMBANKHE006083/YEM-791 |
植物拉丁名: |
|
功能与主治: | To promote the flow of qi and blood, and to induce diuresis./Acute tonsillitis, pharyngolaryngitis, infection of upper respiratory tract, conjunctivitis, jaundice, gastroenteritis, dysentery, child indigestion, food poisoning, salpingitis, acute endometritis, chronic endometritis, acute pelvic inflammation, vaginitis, sore and boil, burns and scalds. |
药用植物名: | 天仙藤 |
药名: | 大黄藤 |
来源: | 云南民族药物志：第四卷 |
药用部位: | root, stem or leaf |
使用民族: | 瑶族/壮族 |
治疗类型: | 祛风湿散寒药 |
TCM_ID_id: | 2199 |
SymMap_id: | 396 |
TCMSP_id: | 1054 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000511 | 3-O-syringyl-taraxerol | ||||
| TCMBANKIN000570 | Palmidin A | 17062-55-4; UNII-RF802M0XYX; palmidin a; Aloeemodin-emodin bianthrone; 10-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl]-1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracen-9-one; RF802M0XYX; AC1NSZET; 10-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9H-anthracen-9-yl]-1,3,8-trihydroxy-6-methyl-10H-anthracen-9-one; 2,4,4',5,5'-PENTAHYDROXY-2'-(HYDROXYMETHYL)-7-METHYL-9H,9'H-[9,9'-BIANTHRACENE]-10,10'-DIONE; (9,9'-Bianthracene)-10,10'(9H,9'H)-dione, 2,4,4',5,5'-pentahydroxy-2'-(hydroxymethyl)-7-methyl-; palmidin A | C30H22O8 | 510.5 g/mol | CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2C4C5=C(C(=CC=C5)O)C(=O)C6=C4C=C(C=C6O)CO)C=C(C=C3O)O |
| TCMBANKIN002667 | allantoin | [2,5-dioxo-imidazolidin-(4e)-ylidene]-urea; (2,5-dioxoimidazol-4-yl)urea; AKOS016004588; AJ-81964; 2AL; AX8170921; BG00903559; DTXSID00425870; KB-212680; X4187; 1-(2,5-DIOXO-2,5-DIHYDRO-1H-IMIDAZOL-4-YL)UREA; CTK8C1374; AC1OA9WW; SCHEMBL9203157; TC-155121; AK-55526; 2,5-DIOXO-1H-IMIDAZOL-4-YLUREA; ZINC24779397; 105245-87-2; ANW-66376 | C4H6N4O3 | 158.12 | C1(C(=O)NC(=O)N1)NC(=O)N |
| TCMBANKIN006996 | Ziebeimine | ziebeimine | C27H43NO2 | 413.64 | CC1CCC2C(C3=C(CN2C1)C4CC5C(C4CC3)CC(C6C5(CCC(C6)O)C)O)C |
| TCMBANKIN007862 | peumine | ||||
| TCMBANKIN007925 | fibraurin | C20H20O7 | 372.4 g/mol | CC12CC=C3C(=O)OC(CC3(C1C4C5C(C2(C(=O)O4)O)O5)C)C6=COC=C6 | |
| TCMBANKIN009757 | trans-communicacid methyl ester | C21H32O2 | CC(=CCC1C(=C)CCC2C1(CCCC2(C)C(=O)OC)C)C=C | ||
| TCMBANKIN010590 | fibleucin | C20H20O6 | 356.4 g/mol | CC12CC=C3C(=O)OC(CC3(C1C4C=CC2(C(=O)O4)O)C)C5=COC=C5 | |
| TCMBANKIN017950 | aristoiochis acid | ||||
| TCMBANKIN018528 | hapepunine 3-o-α-l-rhamnosyl-(1→2)-β-d-glucopyranoside | C40H67NO11 | |||
| TCMBANKIN020120 | Peiminoside | peiminoside | C33H55NO7 | 577.8 g/mol | CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(C6C5(CCC(C6)OC7C(C(C(C(O7)C)O)O)O)C)O)(C)O |
| TCMBANKIN022945 | peiminine | Peiminine; Raddeamine; Imperialine; Sipeimine; Fritillarine; zhebeinine | C27H43NO3 | 429.6 g/mol | CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(=O)C6C5(CCC(C6)O)C)(C)O |
| TCMBANKIN023799 | solanidine-3-o-α-l-rhamnopyranosyl-(1→2)-β-d-glucopyranosyl-(1→4)-β-d-glucopyrano-side | ||||
| TCMBANKIN023946 | Corydalmine | corydalmine ; corydalmine | C20H23NO4 | 341.4 | COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C(=C(C=C4)O)OC)OC |
| TCMBANKIN025202 | Chaksine | 486-53-3; (3R,7R,11R,15R)-3,11-bis[(4R)-2-amino-4,5-dihydro-3H-imidazol-4-yl]-7,15-dimethyl-1,9-dioxacyclohexadecane-2,10-dione; C09940; 1,9-Dioxacyclohexadecane-2,10-dione, 3,11-bis(2-amino-4,5-dihydro-1H-imidazol-4-yl)-7,15-dimethyl-, (3R-(3R*(R*),7R*,11R*(R*),15R*))-; chaksine; (3R,7R,11R,15R)-3,11-bis[(4R)-2-amino-4,5-dihydro-3H-imidazol-4-yl]-7,15-dimethyl-1,9-dioxacyclohexadecane-2,10-quinone | C22H38N6O4 | 450.57 | CC1CCCC(C(=O)OCC(CCCC(C(=O)OC1)C2CNC(=N2)N)C)C3CNC(=N3)N |
| TCMBANKIN026421 | xylopinine | C21H25NO4 | 355.4 g/mol | COC1=C(C=C2C3CC4=CC(=C(C=C4CN3CCC2=C1)OC)OC)OC | |
| TCMBANKIN026871 | apicidin | cyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl) | C34H49N5O6 | 623.8 g/mol | CCC(C)C1C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC3=CN(C4=CC=CC=C43)OC)CCCCCC(=O)CC |
| TCMBANKIN030371 | ligballinol | C18H18O4 | C1C2C(COC2C3=CC=C(C=C3)O)C(O1)C4=CC=C(C=C4)O | ||
| TCMBANKIN031607 | Pelargonidin-3,5-diglucoside | pelargonidin-3,5-diglucoside | C27H31ClO15 | 631 g/mol | C1=CC(=CC=C1C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O)O.[Cl-] |
| TCMBANKIN036815 | berberine | berberine ; isoquinoline alkaloid | C20H18NO4 | 337 | C12=N(C([H])([H])C([H])([H])c(c([H])c(OC([H])([H])O3)c3c4[H])c14)C([H])=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C5[H])C5=C2[H] |
| TCMBANKIN036983 | trans-communol | C20H32O | CC(=CCC1C(=C)CCC2C1(CCCC2(C)CO)C)C=C | ||
| TCMBANKIN037830 | Picropodophyllin | (10R,11S,16R)-16-hydroxy-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0;{3,7}.0;{11,15}]hexadeca-1,3(7),8-trien-12-one; Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R-(5-alpha,5a-alpha,8a-alpha,9-alpha))-; WLN: T E5 C665 FVO NO PO OHTT&&J DR CO1 DO1 EO1& JQ; Picropodophyllin; KBioGR_002538; 5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, [5R-(.alpha.-5a.alpha.,8a.alpha.,9.alpha.)]; Insulin-like Growth Factor-1 Receptor Inhibitor; SPECTRUM1504410; KBioSS_002116; BRN 0099161; NSC 36407; SCHEMBL13661743; Spectrum4_001836; IGF-1R Inhibitor, PPP; Spectrum3_001671; KBio2_004684; Lignans; (5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofurano[5,6-f][1,3]benzodioxol-8-one; KBio2_007252; C10871; SDCCGMLS-0066757.P001; Spectrum2_000520; AIDS006792; KBio3_002701; SPBio_000479; Picropodophyllotoxin; CCG-203057; AIDS-006792; KBio2_002116; 17434-18-3; Spectrum5_000631; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, [5R-(5.alpha.,5a.alpha.,8a.alpha.,9.alpha.)]-; Picropodophyllin (8CI); Spectrum_001636; 477-47-4; BSPBio_003481; (5R,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one; NCGC00161923-01; AC1L9DV2; NSC36407 | 414.41 | ||
| TCMBANKIN038909 | verticinone | MolPort-006-823-865; Cevan-6-one, 3,20-dihydroxy-, (3beta,5alpha)-; CS-3732; AC1L50EW; 3beta,20-Dihydroxy-5alpha-cevan-6-one; UNII-QUB07U6VTQ; ZINC30727228; C10808; 059P104; Kashmirine; Fritillarine;; Fritillarine; CHEBI:5886; CCG-208360; C-22230; C27H43NO3; AKOS015895686; Verticinone;; Kashmirine;; Q-100214; AC1Q6P7C; QUB07U6VTQ; MFCD00210542; Zhebeinone; Peiminine; AC-7988; 1361-22-4; SCHEMBL5956998; ST51051241; 18059-10-4; 1357-77-3; 1357-21-7; HY-N0213; 1416-43-9; X1200 | C27H43NO3 | 429.64 | CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(=O)C6C5(CCC(C6)O)C)(C)O |
| TCMBANKIN038949 | (+)-1-Hydroxypinoresinol | 374.384 | |||
| TCMBANKIN039153 | Ebeiensine | 3-hydroxy-3',6',10,11b-tetramethylspiro[1,2,3,4,4a,6,6a,6b,7,8,11,11a-dodecahydrobenzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-5-one; AC1NSZH8 | 427.6 g/mol | ||
| TCMBANKIN040541 | Ebeinone | 411.6 g/mol | |||
| TCMBANKIN040689 | ent-Kaur-15-en-17-ol | Kaur-15-en-17-ol; Ent-kaur-15-en-17-ol; 14696-33-4 | 288.47 | ||
| TCMBANKIN041404 | isobaimonidine | C27H45NO3 | |||
| TCMBANKIN041435 | ent-Kauran-16β,17-diol | ||||
| TCMBANKIN041581 | ent-16α-Methoxy-kauran-17-ol | ent-16alpha-methoxy-kauran-17-ol | |||
| TCMBANKIN042548 | ent-Kauran-16α,17-diol | ||||
| TCMBANKIN042997 | fritillarizine | STOCK1N-49967; AKOS030501866; 76733-86-3; ZINC70688102; BG01702139; MCULE-6057699517; (1R,2S,6S,9S,10S,11S,14S,15S,20R,23R,24S)-6,10,23-TRIMETHYL-4-AZAHEXACYCLO[12.11.0.0(2),(1)(1).0?,?.0(1)?,(2)?.0(1)?,(2)(3)]PENTACOS-17-ENE-10,20-DIOL; MolPort-002-524-349 | C27H43NO2 | 413.6 g/mol | CC1CCC2C(C3CCC4C5CC=C6CC(CCC6(C5CC4C3CN2C1)C)O)(C)O |
| TCMBANKIN043095 | Zhebeininoside | ||||
| TCMBANKIN043389 | verticinone-n-oxide | ||||
| TCMBANKIN045336 | Hapepunine | AC1O3DF4; 68422-01-5; (3S,8S,9S,10R,13S,14S,16S)-17-[(1S)-1-(1,5-dimethylpiperidin-2-yl)ethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diol | 429.7 g/mol | ||
| TCMBANKIN045520 | solanidine-3-o-α-l-rhamnopyranosyl-(1→2)-β-d-glucopyranoside | ||||
| TCMBANKIN046426 | baimonidine | C27H45NO3 | |||
| TCMBANKIN046779 | ent-17-norkauran-16-one | C19H30O | 274.44 | CC1(CCCC2(C1CCC34C2CCC(C3)C(=O)C4)C)C | |
| TCMBANKIN049013 | ent-(16S)-atisan-13,17-oxide | ent-(16s)-atisan-13,17-oxide | C20H32O | 288.47 | CC1(CCCC2(C1CCC34C2CC5C(C3)COC5C4)C)C |
| TCMBANKIN057998 | magnoflorine | NSC150447; AKOS025401511; Magnoflorine; Escholine Iodide; C20H24NO4.I; Magnoflorine, iodide; Thalictrine Iodide; Magnoflorine Iodide (6CI,7CI); N2506; AC-20269; 4H-Dibenzo(de,g)quinolinium, 5,6,6a,7-tetrahydro-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-, iodide, (S)-; Magnoflorine-iodide; NSC 150447; MAGNOFLORINE IODIDE; MAGNOFLORINE IODIDE, (+)-(RG); Magnoflorineiodide; BG01755204; (+)-Magnoflorine Iodide; CHEMBL494052; Corytuberine Methiodide; MolPort-006-069-296; NSC-150447; 4277-43-4; (+)-MAGNOFLORINE IODIDE; 1,11-Dihydroxy-2,10-dimethoxy-6-methyl-6a; AK608288; A-aporphinium Iodide; 8167AH; DTXSID00195420; (6aS)-5,6,6a,7-Tetrahydro-1,11-dihydroxy-2,10-dimethoxy-6,6-dimethyl-4H-dibenzo[de,g]quinolinium Iodide; magnoflorine; (+)-magnoflorine | C20H24NO4+ | 342.4 g/mol | C[N+]1(CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)O)OC)C |
| TCMBANKIN058450 | ADO | nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside | C10H13N5O4 | 267.24 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN059599 | taraxe-rol | C30H50O | 426.7 g/mol | CC1(CCC2(CC=C3C4(CCC5C(C(CCC5(C4CCC3(C2C1)C)C)O)(C)C)C)C)C | |
| TCMBANKIN059668 | 16, 17-epoxykaurane | C20H32O | 288.47 | CC1(CCCC2(C1CCC34C2CCC(C3)C5(C4)CO5)C)C | |
| TCMBANKIN060039 | THM | C10H14N2O5 | 242.23 g/mol | CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O | |
| TCMBANKIN060044 | 5-methyluracil | C5H6N2O2 | 126.11 g/mol | CC1=CNC(=O)NC1=O | |
| TCMBANKIN060385 | (16r)-ent-7β-hydroxykauran-15-one | C20H32O2 | CC1C2CCC3C4(CCCC(C4CC(C3(C2)C1=O)O)(C)C)C | ||
| TCMBANKIN060428 | Peimisine | C27H41NO3 | 427.6 g/mol | CC1CC2C(C(C3(O2)CCC4C5CC(=O)C6CC(CCC6(C5CC4=C3C)C)O)C)NC1 | |
| TCMBANKIN060578 | Solanidine | C27H43NO | 397.6 g/mol | CC1CCC2C(C3C(N2C1)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C | |
| TCMBANKIN060582 | Verticine | C27H45NO3 | 431.7 g/mol | CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(C6C5(CCC(C6)O)C)O)(C)O | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061585 | Ferulaldehyde | AIDS097066; AIDS-097066; ferulaldehyde ; 382051_ALDRICH; 4-Hydroxy-3-methoxycinnamaldehyde; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal; 2-Propenal, 3-(4-hydroxy-3-methoxyphenyl), (E)-; 3-(4-hydroxy-3-methoxy-phenyl)prop-2-enal; 3-(4-hydroxy-3-methoxy-phenyl)acrolein; (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enal; InChI=1/C10H10O3/c1-13-10-7-8(3-2-6-11)4-5-9(10)12/h2-7,12H,1H3/b3-2; CHEBI:16547; C02666; (E)-3-(4-hydroxy-3-methoxy-phenyl)acrolein; 458-36-6; Coniferyl aldehyde; ferulaldehyde; 3-(4-hydroxy-3-methoxyphenyl)prop-2-enal; Coniferaldehyde; coniferylaldehyde; coniferaldehyde; trans-coniferyl aldehyde; coniferyl aldehyde; ferulylaldehyde; (E)-ferulaldehyde | C10H10O3 | 178.18 | COC1=C(C=CC(=C1)C=CC=O)O |
| TCMBANKIN061671 | dl-tetrahydropalmatine | dl-tetrahydropalmatine;AIDS002241; 84-38-8; 13a-alpha-Berbine, 2,3,9,10-tetramethoxy-; CHEBI:16563; 6H-Dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (S)-; (S)-5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine; AIDS-002241; C02890; Hyndarine; (-)-Corydalis; 4880-82-4 (HCL); NSC36363 (HCL); InChI=1/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s; 5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine; 5,8,13,13a(S)-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo[a,g]quinolizine; 2-(2,3-Dimethoxy-benzyl)-1-ethyl-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline; BB_NC-1018; Gindarine; Tetrahydropalmatine (6CI); Berbine, 2,3,9,10-tetramethoxy- (8CI); Tetrahydropalmatine; l-Tetrahydropalmatine; (S)-Tetrahydropalmatine; Caseanine; 6H-Dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-; Rotundine; (13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline; 483-14-7; (13aS)-2,3,9,10-tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline; 6H-dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (13aS)-; (-)-Tetrahydropalmatine;2,3,9,10-Tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[3,2-a]isoquinoline hydrochloride; 2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline hydrochloride; AKOS024399264; MolPort-002-321-247; Berbine,3,9,10-tetramethoxy-, hydrochloride; NSC-132057; NSC-209411; 2,3,9,10-Tetramethoxyberbine hydrochloride; 6024-85-7; CHEMBL1412574; NSC132058; Palmatine, hydrochloride, (.+-.)-; 6H-Dibenzo[a, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride, (R)-; Tetrahydropalmatine hydrochloride; 024T857; C-55689; MCULE-7006385138; Palmatine, hydrochloride, (+)-; A832652; 6H-Dibenzo[a, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride; MLS000029596; Ambotz6024-85-7; 2506-20-9; FT-0698667; 6H-Dibenzo[a, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride, (.+-.)-; WLN: T D6 B666 KN&TT&J GO1 HO1 PO1 QO1 &GH; AC1O7ERI; NSC132057; NSC-132058; MLS002535962; AK310574; 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline hydrochloride; AC-8031; 13a.beta.-Berbine,3,9,10-tetramethoxy-, hydrochloride; Berbine,3,9,10-tetramethoxy-, hydrochloride, (+)-; NSC209411; Berbine,3,9,10-tetramethoxy-, hydrochloride, (.+-.)-; 3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5H-6000000-azatetraphene hydrochloride; SCHEMBL3502167; AC1Q3C4E; D-Tetrahydropalmatine hydrochloride; Tetrahydropalmatine, HCl; SMR000008833;(13aR)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline;Hyndarin;tetrahydropalmatine;L-tetrahydropalmatine;STOCK1N-14407 | C21H25NO4 | 355.4 g/mol | COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC |
| TCMBANKIN061673 | jatrorrizine | Jatrorrhizine, iodide; 2,9,10-trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol iodide; iatrorrhizine; JATRORRHIZINE IODIDE; jatrorhizinc; CHEMBL1990190; NSC-93137; AC1NURFL; Q-100433; Ambap3621-38-3; 7,8,13,13alpha-Tetradehydro-3-hydroxy-2,9,10-trimethoxyberbinium; jatrorrhizine; 1168-00-9; KB-78657; NSC93137; jatrorrhizine; jatrorrhizine | C20H20NO4+ | 338.4 g/mol | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)O)OC)OC |
| TCMBANKIN061674 | palmatin;palmatine | V1557; 5,6-Dihydro-2,3,9,10-tetramethoxydibenzo(a,g)quinolizinium hydroxide; Calystigine; Palmatine chloride; palmatine ; 6771L5MN8S; UNII-6771L5MN8S; MolPort-039-138-801; 3486-67-7 (Parent); Palmatine hydroxide; 131-04-4; BG01657711; AC1L43OM; Palmatinium hydroxide; LS-61262; DTXSID60156830; 7,8,13,13a-Tetradehydro-2,3,9,10-tetramethoxyberbinium hydroxide; Dibenzo(a,g)quinolizinium, 5,6-dihydro-2,3,9,10-tetramethoxy-, hydroxide; 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium hydroxide; AS-17724 | C21H22NO4+ | 352.4 g/mol | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC |
| TCMBANKIN061675 | berberime | berberine ; isoquinoline alkaloid; berberine | C20H18NO4+ | 336.4 g/mol | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC |
| TCMBANKIN061751 | Sinapaldehyde | (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-propenal; 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal; 3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enal; 4206-58-0; (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal; 3,5-Dimethoxy-4-hydroxycinnamaldehyde; sinapaldehyde; 3-(4-hydroxy-3,5-dimethoxy-phenyl)acrolein; 3,5-Dimethoxy-4-hydroxycinnamaldehyde (E); (E)-3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enal; MEGxp0_001085; (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal; Sinapinaldehyde; trans-3,5-Dimethoxy-4-hydroxycinnamaldehyde; 2-Propenal, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, (E)-; (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylaldehyde; (E)-3-(4-hydroxy-3,5-dimethoxy-phenyl)acrolein; C05610; ACon1_001103; 382159_ALDRICH; Sinapoyl aldehyde; (2E)-3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenal; sinapyl aldehyde; CHEBI:27949;sinapal dehyde | C11H12O4 | 208.21 | COC1=CC(=CC(=C1O)OC)C=CC=O |
| TCMBANKIN061761 | Zhebeiresinol | zhebeiresinol;caruilignan d | C14H16O6 | 280.27 | COC1=CC(=CC(=C1O)OC)C2C3COC(=O)C3CO2 |
| TCMBANKIN061806 | aristolochicacid iva | aristolochic acid Ⅳa; aristolochic acid D;Aristoloside_qt | C17H11NO8 | 357.27g/mol | COC1=CC(=CC2=C3C(=C(C=C12)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab